SCHEMBL26567446

SCHEMBL26567446

COc1ccc(CNC(=O)Nc2ccc(CC(=O)N3CCC[C@H]3C)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.57
PKM P14618 1/20 0.56
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
TSHR P16473 1/20 0.53
CYP2C19 P33261 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
HTT P42858 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
HPGD P15428 2/20 0.50
POLB P06746 2/20 0.50
GAA P10253 1/20 0.50
HRH3 Q9Y5N1 1/20 0.50
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26101520 1.00 SMN1; SMN2 (0.57) SMN1; SMN2PKMNPC1RAB9ACYP1A2
SCHEMBL26100222 0.88 SMN1; SMN2 (0.55) SMN1; SMN2PKMNPC1RAB9ACYP1A2
SCHEMBL26102205 0.88 SMN1; SMN2 (0.55) SMN1; SMN2PKMNPC1RAB9ACYP1A2
SCHEMBL23747779 0.88 HPGD (0.67) SMN1; SMN2NPC1RAB9AHPGDPOLB
SCHEMBL26567135 0.88 HPGD (0.67) SMN1; SMN2NPC1RAB9AHPGDPOLB
SCHEMBL23747793 0.87 PKM (0.58) SMN1; SMN2PKMNPC1RAB9ACYP2C9
SCHEMBL26101993 0.87 SMN1; SMN2 (0.54) SMN1; SMN2PKMNPC1RAB9AHDAC1
SCHEMBL23747791 0.86 PKM (0.55) SMN1; SMN2PKMNPC1RAB9AHDAC1
SCHEMBL23747575 0.86 DPP4 (0.58) SMN1; SMN2PKMNPC1RAB9AHDAC1
SCHEMBL26102253 0.86 DPP4 (0.58) SMN1; SMN2PKMNPC1RAB9AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 SMN1; SMN2 1161/4885PKM 401/4885NPC1 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.